AXCELIS TECHNOLOGIES INC (ACLS) Fundamental Analysis & Valuation

NASDAQ:ACLS • US0545402085

84.06 USD
+1.82 (+2.21%)
At close: Mar 9, 2026
84.06 USD
0 (0%)
After Hours: 3/9/2026, 5:32:55 PM

This ACLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall ACLS gets a fundamental rating of 6 out of 10. We evaluated ACLS against 115 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACLS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. ACLS Profitability Analysis

1.1 Basic Checks

  • ACLS had positive earnings in the past year.
  • In the past year ACLS had a positive cash flow from operations.
  • ACLS had positive earnings in each of the past 5 years.
  • In the past 5 years ACLS always reported a positive cash flow from operatings.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • With a decent Return On Assets value of 8.83%, ACLS is doing good in the industry, outperforming 79.13% of the companies in the same industry.
  • The Return On Equity of ACLS (11.62%) is better than 75.65% of its industry peers.
  • ACLS has a better Return On Invested Capital (8.93%) than 79.13% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ACLS is significantly above the industry average of 10.50%.
  • The last Return On Invested Capital (8.93%) for ACLS is well below the 3 year average (16.09%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROIC 8.93%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ACLS's Profit Margin of 14.33% is fine compared to the rest of the industry. ACLS outperforms 73.91% of its industry peers.
  • ACLS's Profit Margin has improved in the last couple of years.
  • ACLS's Operating Margin of 14.22% is fine compared to the rest of the industry. ACLS outperforms 71.30% of its industry peers.
  • ACLS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 44.91%, ACLS is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

9

2. ACLS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ACLS is still creating some value.
  • Compared to 1 year ago, ACLS has less shares outstanding
  • The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ACLS has an improved debt to assets ratio.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • ACLS has an Altman-Z score of 6.72. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ACLS (6.72) is better than 62.61% of its industry peers.
  • ACLS has a debt to FCF ratio of 0.40. This is a very positive value and a sign of high solvency as it would only need 0.40 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.40, ACLS belongs to the best of the industry, outperforming 81.74% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that ACLS is not too dependend on debt financing.
  • ACLS's Debt to Equity ratio of 0.04 is fine compared to the rest of the industry. ACLS outperforms 61.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Altman-Z 6.72
ROIC/WACC0.79
WACC11.36%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ACLS has a Current Ratio of 4.77. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • ACLS has a Current ratio of 4.77. This is in the better half of the industry: ACLS outperforms 72.17% of its industry peers.
  • A Quick Ratio of 3.11 indicates that ACLS has no problem at all paying its short term obligations.
  • The Quick ratio of ACLS (3.11) is better than 63.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.77
Quick Ratio 3.11
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. ACLS Growth Analysis

3.1 Past

  • The earnings per share for ACLS have decreased strongly by -20.81% in the last year.
  • The Earnings Per Share has been growing by 29.06% on average over the past years. This is a very strong growth
  • The Revenue for ACLS has decreased by -17.57% in the past year. This is quite bad
  • The Revenue has been growing by 12.07% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.80% on average over the next years.
  • ACLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.32% yearly.
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. ACLS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.26 indicates a rather expensive valuation of ACLS.
  • Based on the Price/Earnings ratio, ACLS is valued cheaply inside the industry as 92.17% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.46. ACLS is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 22.59, the valuation of ACLS can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than the industry average as 77.39% of the companies are valued more expensively.
  • ACLS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.26
Fwd PE 22.59
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 85.22% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ACLS is valued cheaper than 88.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.13
EV/EBITDA 14.36
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The excellent profitability rating of ACLS may justify a higher PE ratio.
  • A cheap valuation may be justified as ACLS's earnings are expected to decrease with -2.80% in the coming years.
PEG (NY)N/A
PEG (5Y)0.59
EPS Next 2Y-2.8%
EPS Next 3YN/A

0

5. ACLS Dividend Analysis

5.1 Amount

  • ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACLS Fundamentals: All Metrics, Ratios and Statistics

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (3/9/2026, 5:32:55 PM)

After market: 84.06 0 (0%)

84.06

+1.82 (+2.21%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners107.81%
Inst Owner Change3.38%
Ins Owners0.57%
Ins Owner Change-1.09%
Market Cap2.58B
Revenue(TTM)839.05M
Net Income(TTM)120.24M
Analysts50.91
Price Target107.25 (27.59%)
Short Float %16.46%
Short Ratio6.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.43%
Min EPS beat(2)18.27%
Max EPS beat(2)30.58%
EPS beat(4)4
Avg EPS beat(4)66.14%
Min EPS beat(4)18.27%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)40.33%
EPS beat(12)12
Avg EPS beat(12)31.33%
EPS beat(16)16
Avg EPS beat(16)28.84%
Revenue beat(2)2
Avg Revenue beat(2)6.67%
Min Revenue beat(2)4.69%
Max Revenue beat(2)8.66%
Revenue beat(4)4
Avg Revenue beat(4)4.62%
Min Revenue beat(4)2.12%
Max Revenue beat(4)8.66%
Revenue beat(8)7
Avg Revenue beat(8)2.58%
Revenue beat(12)11
Avg Revenue beat(12)2.76%
Revenue beat(16)15
Avg Revenue beat(16)2.72%
PT rev (1m)-2.39%
PT rev (3m)0.36%
EPS NQ rev (1m)-31.58%
EPS NQ rev (3m)-32.49%
EPS NY rev (1m)-18.93%
EPS NY rev (3m)-19.69%
Revenue NQ rev (1m)-6.96%
Revenue NQ rev (3m)-7.29%
Revenue NY rev (1m)-3.8%
Revenue NY rev (3m)-3.86%
Valuation
Industry RankSector Rank
PE 17.26
Fwd PE 22.59
P/S 3.08
P/FCF 24.13
P/OCF 21.83
P/B 2.5
P/tB 2.5
EV/EBITDA 14.36
EPS(TTM)4.87
EY5.79%
EPS(NY)3.72
Fwd EY4.43%
FCF(TTM)3.48
FCFY4.14%
OCF(TTM)3.85
OCFY4.58%
SpS27.31
BVpS33.68
TBVpS33.68
PEG (NY)N/A
PEG (5Y)0.59
Graham Number60.75
Profitability
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROCE 10.25%
ROIC 8.93%
ROICexc 13.17%
ROICexgc 13.17%
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
FCFM 12.75%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ROICexc(3y)30.86%
ROICexc(5y)36.82%
ROICexgc(3y)30.86%
ROICexgc(5y)36.82%
ROCE(3y)18.46%
ROCE(5y)20.85%
ROICexgc growth 3Y-38.1%
ROICexgc growth 5Y-2.58%
ROICexc growth 3Y-38.1%
ROICexc growth 5Y-2.58%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Debt/EBITDA 0.3
Cap/Depr 64.13%
Cap/Sales 1.35%
Interest Coverage 250
Cash Conversion 86.4%
Profit Quality 89%
Current Ratio 4.77
Quick Ratio 3.11
Altman-Z 6.72
F-Score5
WACC11.36%
ROIC/WACC0.79
Cap/Depr(3y)99.74%
Cap/Depr(5y)94.41%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.37%
Profit Quality(3y)69.44%
Profit Quality(5y)92.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.57%
EBIT growth 3Y-17.49%
EBIT growth 5Y15.52%
EBIT Next Year-9.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.81%
FCF growth 3Y-19.47%
FCF growth 5Y11.43%
OCF growth 1Y-15.99%
OCF growth 3Y-18.13%
OCF growth 5Y11.16%

AXCELIS TECHNOLOGIES INC / ACLS FAQ

Can you provide the ChartMill fundamental rating for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACLS.


Can you provide the valuation status for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 5 / 10 to AXCELIS TECHNOLOGIES INC (ACLS). This can be considered as Fairly Valued.


What is the profitability of ACLS stock?

AXCELIS TECHNOLOGIES INC (ACLS) has a profitability rating of 8 / 10.


What is the valuation of AXCELIS TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 17.26 and the Price/Book (PB) ratio is 2.5.


What is the earnings growth outlook for AXCELIS TECHNOLOGIES INC?

The Earnings per Share (EPS) of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -23.59% in the next year.